title: Naloxegol oxalate, pirfenidone, and nintedanib.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
authors.forename: Michelle M
authors.initials: MM
authors.lastname: Jeon
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects; D003248:Constipation / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D003672:Defecation / Q000187:drug effects*; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000175:diagnosis / Q000188:drug therapy*; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D008168:Lung / Q000187:drug effects / Q000473:pathology; D009019:Morphinans / Q000009:adverse effects / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D011728:Pyridones / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000701:Analgesics, Opioid; D007211:Indoles; D009019:Morphinans; D009292:Narcotic Antagonists; D047428:Protein Kinase Inhibitors; D011728:Pyridones; D011092:Polyethylene Glycols; C000589308:naloxegol; C093844:pirfenidone; C530716:nintedanib